Cepheid Eyes EUA from FDA for H1N1 Test

The firm expects to receive an Emergency Use Authorization soon from FDA, followed by a filing for full FDA clearance. A company official also updated investors on Cepheid's pipeline of tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.